DekaBank Deutsche Girozentrale - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 147 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2022$231,000
-19.2%
31,2000.0%0.00%0.0%
Q1 2022$286,000
-39.9%
31,200
+9.9%
0.00%0.0%
Q4 2021$476,0000.0%28,400
+2.9%
0.00%0.0%
Q3 2021$476,000
+13.6%
27,6000.0%0.00%0.0%
Q2 2021$419,000
+8.8%
27,6000.0%0.00%0.0%
Q1 2021$385,000
-33.0%
27,6000.0%0.00%
-50.0%
Q4 2020$575,000
+546.1%
27,600
+294.3%
0.00%
Q3 2020$89,000
-8.2%
7,000
-2.8%
0.00%
-100.0%
Q3 2019$97,000
-66.8%
7,200
-50.0%
0.00%0.0%
Q2 2019$292,000
-18.0%
14,400
+63.6%
0.00%
-50.0%
Q1 2019$356,000
+43.5%
8,800
+22.2%
0.00%0.0%
Q4 2018$248,000
-30.3%
7,200
-18.2%
0.00%0.0%
Q3 2018$356,000
+9.5%
8,800
-2.2%
0.00%0.0%
Q2 2018$325,000
-5.0%
9,0000.0%0.00%0.0%
Q1 2018$342,000
+159.1%
9,000
-2.2%
0.00%
+100.0%
Q4 2017$132,0000.0%9,2000.0%0.00%0.0%
Q3 2017$132,000
-1.5%
9,2000.0%0.00%0.0%
Q2 2017$134,000
-27.6%
9,2000.0%0.00%
-50.0%
Q1 2017$185,000
-49.3%
9,200
-43.2%
0.00%
-50.0%
Q2 2016$365,000
+48.4%
16,200
+23.7%
0.00%
+33.3%
Q1 2016$246,00013,1000.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 2,932,865$48,304,0003.48%
Camber Capital Management LP 2,950,000$48,587,0002.47%
Trellus Management Company, LLC 87,873$1,447,0002.42%
Redmile Group, LLC 4,648,570$76,562,0001.83%
Baupost Group 8,308,900$136,848,0001.51%
MAVERICK CAPITAL LTD 4,958,431$81,665,0001.19%
Artal Group S.A. 1,750,000$28,823,0001.11%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$2,882,0000.36%
12 West Capital Management LP 158,700$2,614,0000.16%
WASATCH ADVISORS LP 1,101,103$18,135,0000.15%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders